[Multiple latency test in a patient with episodes of sleep induced by pergolide]

Rev Neurol. 2002 Jun;34(12):1140-1.
[Article in Spanish]

Abstract

Objective: Recently, there have been report sleep attacks in parkinsonian patients as a side effect of pramipexole and ropinirole. We report a patient with similar episodes related with pergolide.

Case report: A 64 year old man with rigid akinetic parkinsonism, treated with carbidopa/levodopa and pergolide, developed sudden, irresistible sleep episodes after increasing the dose of pergolide to 2.25 mg/day because of bad control of parkinsonian symptoms. These episodes started 30 minutes after each dose of pergolide and lasted 2 hours. Following reduction of the dose of pergolide to 1.5 mg/day the sleep episodes disappeared. Two double blind multiple sleep latency tests were performed, one after intaking pergolide and other after intaking placebo.

Results: The latencies to sleep onset were lower with pergolide than with placebo, but the differences did not reach statistical significance. There was no premature REM sleep onset.

Conclusion: Sleep episodes are likely a not specific effect of dopamine agonists

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Controlled Clinical Trials as Topic
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Pergolide / adverse effects*
  • Pergolide / therapeutic use
  • Sleep Wake Disorders / chemically induced*

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Pergolide